The U.S. Securities and Exchange Commission charged a former executive of Medivation Inc. with insider trading Tuesday in California Northern District Court. The suit accuses Matthew Panuwat, Medivation's former head of business development, of conducting trades in 2016 based on advance knowledge of Medivation's acquisition by Pfizer. Attorneys have not yet appeared for the defendant. The case is 3:21-cv-06322, Securities and Exchange Commission v. Panuwat.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.

Read the complaint here:

|